相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
T. Reiman et al.
ANNALS OF ONCOLOGY (2012)
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study
George Pentheroudakis et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis
Manimalha Balasubramani et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2011)
Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts
Maria T. Baquero et al.
BREAST CANCER RESEARCH (2011)
Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells
T-Y Jeon et al.
BRITISH JOURNAL OF CANCER (2010)
Human Microtubule-Associated-Protein Tau Regulates the Number of Protofilaments in Microtubules: A Synchrotron X-Ray Scattering Study
M. C. Choi et al.
BIOPHYSICAL JOURNAL (2009)
Gene expression profiles in mouse embryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motility
Danielle N. Ringhoff et al.
BMC GENOMICS (2009)
Quantitative Multiplexed Analysis of ErbB Family Coexpression for Primary Breast Cancer Prognosis in a Large Retrospective Cohort
Jennifer M. Giltnane et al.
CANCER (2009)
Coordinated Expression of Stathmin Family Members by Far Upstream Sequence Element-Binding Protein-1 Increases Motility in Non-Small Cell Lung Cancer
Stephan Singer et al.
CANCER RESEARCH (2009)
Membrane transport of WAVE2 and lamellipodia formation require Pak1 that mediates phosphorylation and recruitment of stathmin/Op18 to Pak1-WAVE2-kinesin complex
Kazuhide Takahashi et al.
CELLULAR SIGNALLING (2009)
Overexpression of Class III β-Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma
Daisuke Aoki et al.
CLINICAL CANCER RESEARCH (2009)
Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients
Wang Xi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma
San-Hua Wei et al.
ACTA HISTOCHEMICA (2008)
Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesis
Kenneth J. Rosenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy:: an immunohistochemical study
Rastko Golouh et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American society of clinical Oncology/College of American pathologists guidelines:: tumor heterogeneity in breast cancer and its implications for tissue Microarray based assessment of outcome
Christopher B. Moeder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Microtubule-associated proteins as targets in cancer chemotherapy
Kumar M. R. Bhat et al.
CLINICAL CANCER RESEARCH (2007)
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
Lao H. Saal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells
Elizabeth Alli et al.
MOLECULAR PHARMACOLOGY (2007)
Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53
E. Alli et al.
ONCOGENE (2007)
Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome
Marisa Dolled-Filhart et al.
CANCER RESEARCH (2006)
Stathmin strongly increases the minus end catastrophe frequency and induces rapid treadmilling of bovine brain microtubules at steady state in vitro
T Manna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis
A McCabe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A tumorigenic subpopulation with stem cell properties in melanomas
D Fang et al.
CANCER RESEARCH (2005)
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
R Rouzier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Conserved microtubule-actin interactions in cell movement and morphogenesis
OC Rodriguez et al.
NATURE CELL BIOLOGY (2003)
MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments
J Al-Bassam et al.
JOURNAL OF CELL BIOLOGY (2002)
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours
PA Curmi et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
